BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 21131999)

  • 1. The role of BDNF in depression on the basis of its location in the neural circuitry.
    Yu H; Chen ZY
    Acta Pharmacol Sin; 2011 Jan; 32(1):3-11. PubMed ID: 21131999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
    Masi G; Brovedani P
    CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.
    Castrén E; Rantamäki T
    Dev Neurobiol; 2010 Apr; 70(5):289-97. PubMed ID: 20186711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.
    Rana T; Behl T; Sehgal A; Srivastava P; Bungau S
    J Mol Neurosci; 2021 Oct; 71(10):2008-2021. PubMed ID: 33230708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
    Ghosal S; Bang E; Yue W; Hare BD; Lepack AE; Girgenti MJ; Duman RS
    Biol Psychiatry; 2018 Jan; 83(1):29-37. PubMed ID: 28751069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect evidences of BDNF and NGF as key modulators in depression: role of antidepressants treatment.
    Mondal AC; Fatima M
    Int J Neurosci; 2019 Mar; 129(3):283-296. PubMed ID: 30235967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of brain-derived neurotrophic factor in late-life depression.
    Dwivedi Y
    Am J Geriatr Psychiatry; 2013 May; 21(5):433-49. PubMed ID: 23570887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antidepressant-like effects of Chaihu Shugan San: Dependent on the hippocampal BDNF-TrkB-ERK/Akt signaling activation in perimenopausal depression-like rats.
    Chen XQ; Li CF; Chen SJ; Liang WN; Wang M; Wang SS; Dong SQ; Yi LT; Li CD
    Biomed Pharmacother; 2018 Sep; 105():45-52. PubMed ID: 29843044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of memantine on depression-like behavior, memory deficits and brain mRNA levels of BDNF and TrkB in rats subjected to repeated unpredictable stress.
    Amidfar M; Kim YK; Wiborg O
    Pharmacol Rep; 2018 Jun; 70(3):600-606. PubMed ID: 29680698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF - a key transducer of antidepressant effects.
    Björkholm C; Monteggia LM
    Neuropharmacology; 2016 Mar; 102():72-9. PubMed ID: 26519901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.
    Adachi M; Barrot M; Autry AE; Theobald D; Monteggia LM
    Biol Psychiatry; 2008 Apr; 63(7):642-9. PubMed ID: 17981266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does neurotropin-3 have a therapeutic implication in major depression?
    Pae CU; Marks DM; Han C; Patkar AA; Steffens D
    Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TrkB Signaling in Dorsal Raphe Nucleus is Essential for Antidepressant Efficacy and Normal Aggression Behavior.
    Adachi M; Autry AE; Mahgoub M; Suzuki K; Monteggia LM
    Neuropsychopharmacology; 2017 Mar; 42(4):886-894. PubMed ID: 27634357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.
    Zhang JC; Yao W; Hashimoto K
    Curr Neuropharmacol; 2016; 14(7):721-31. PubMed ID: 26786147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?
    Młyniec K; Singewald N; Holst B; Nowak G
    J Affect Disord; 2015 Mar; 174():89-100. PubMed ID: 25490458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes.
    Xu W; Yao X; Zhao F; Zhao H; Cheng Z; Yang W; Cui R; Xu S; Li B
    Neural Plast; 2020; 2020():8861903. PubMed ID: 33293948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens.
    Furuse K; Ukai W; Hashimoto E; Hashiguchi H; Kigawa Y; Ishii T; Tayama M; Deriha K; Shiraishi M; Kawanishi C
    J Affect Disord; 2019 Mar; 247():97-104. PubMed ID: 30658246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.
    Sheldrick A; Camara S; Ilieva M; Riederer P; Michel TM
    Eur Psychiatry; 2017 Oct; 46():65-71. PubMed ID: 29102768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.
    Zhang JC; Wu J; Fujita Y; Yao W; Ren Q; Yang C; Li SX; Shirayama Y; Hashimoto K
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25628381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Z-Guggulsterone Produces Antidepressant-Like Effects in Mice through Activation of the BDNF Signaling Pathway.
    Liu FG; Hu WF; Wang JL; Wang P; Gong Y; Tong LJ; Jiang B; Zhang W; Qin YB; Chen Z; Yang RR; Huang C
    Int J Neuropsychopharmacol; 2017 Jun; 20(6):485-497. PubMed ID: 28339691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.